PNR three-lens brief
Evidence-based stock research on PNR. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 20.1pp over 30 days. · Trading at 1% of its 52-week range — deep in the lower band.
- Trading at 1% of its 52-week range — deep in the lower band.
- RSI at 28 — technically oversold.
- Underperforming SPY by 20.1pp over 30 days.
- Analyst mean target $102.26 — 30% above current (19 analysts).
- Debt-to-equity of 54.6 — balance-sheet-heavy.
PNR closed at $78.82 (-0.35%) as of 2026-05-04. Market cap: $12.74B. P/E (trailing) 19.8. Positives: analyst mean target $102.26 — 30% above current (19 analysts).. Concerns: trading at 1% of its 52-week range — deep in the lower band.; rSI at 28 — technically oversold.. Last quarter: Revenue $1.04B, net income $160.80M, free cash flow $574.21M.
Why three lenses on PNR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PNRacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PNR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PNR brief"></iframe>